Evidence map›Paper›PMID 32130210›Full record

ArticlePLoS neglected tropical diseases2020

Accounting for population structure reveals ambiguity in the Zaire Ebolavirus reservoir dynamics.

Bram Vrancken, Tony Wawina-Bokalanga, Bert Vanmechelen, Joan Martí-Carreras, Miles W Carroll, Justus Nsio, Jimmy Kapetshi, Sheila Makiala-Mandanda, Jean-Jacques Muyembe-Tamfum, Guy Baele and 4 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bram VranckenKU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Division of Clinical and Epidemiological Virology, Leuven, Belgium.ORCID 0000-0001-6547-5283
Tony Wawina-BokalangaKU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Division of Clinical and Epidemiological Virology, Leuven, Belgium.
Bert VanmechelenKU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Division of Clinical and Epidemiological Virology, Leuven, Belgium.
Joan Martí-CarrerasKU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Division of Clinical and Epidemiological Virology, Leuven, Belgium.
Miles W CarrollResearch and Development Institute, National Infection Service, Public Health England, Porton Down, Wiltshire, United Kingdom.
Justus NsioMinistère de la Santé, Kinshasa, Democratic Republic of the Congo.
Jimmy KapetshiInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Sheila Makiala-MandandaInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Jean-Jacques Muyembe-TamfumInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Guy BaeleKU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Division of Clinical and Epidemiological Virology, Leuven, Belgium.ORCID 0000-0002-1915-7732
Kurt VermeireKU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
Valentijn VergoteKU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Division of Clinical and Epidemiological Virology, Leuven, Belgium.
Steve Ahuka-MundekeInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Piet MaesKU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Division of Clinical and Epidemiological Virology, Leuven, Belgium.ORCID 0000-0002-4571-5232

Funding

Wellcome TrustWellcome Trust 206298/B/17/Z
6 · The paper itself

Abstract

Ebolaviruses pose a substantial threat to wildlife populations and to public health in Africa. Evolutionary analyses of virus genome sequences can contribute significantly to elucidate the origin of new outbreaks, which can help guide surveillance efforts. The reconstructed between-outbreak evolutionary history of Zaire ebolavirus so far has been highly consistent. By removing the confounding impact of population growth bursts during local outbreaks on the free mixing assumption that underlies coalescent-based demographic reconstructions, we find-contrary to what previous results indicated-that the circulation dynamics of Ebola virus in its animal reservoir are highly uncertain. Our findings also accentuate the need for a more fine-grained picture of the Ebola virus diversity in its reservoir to reliably infer the reservoir origin of outbreak lineages. In addition, the recent appearance of slower-evolving variants is in line with latency as a survival mechanism and with bats as the natural reservoir host.

Indexed as

AfricaAnimal DiseasesAnimalsChiropteraDisease ReservoirsEbolavirusGenotypeHemorrhagic Fever, EbolaHumansPhylogeny

Identifiers

PMID32130210
PMCPMC7075637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.